Andrew S. Verderame

Biography

Andrew S. Verderame, MBA, RAC leads our US-based Regulatory staff providing FDA-specific guidance and consulting services. He has over 30 years of involvement in the pharmaceutical industry, including positions of increasing responsibility in pharmaceutical production management, Regulatory CMC, US Regulatory leadership, and as Global Head of Regulatory therapeutic area teams.  He has led over two hundred meetings with FDA, managed multi-site regulatory teams for both large and small pharmaceutical companies, and has presented to FDA Advisory Committees with successful outcomes.

Research Interest

 Clinical Science